Bourgeois F - Search Results

1

National Survey of FACT-Accredited Cell Processing Facilities: Assessing Preparedness for Local Manufacturing of Immune Effector Cells.

Elsallab M, Bourgeois F, Maus MV. Elsallab M, et al. Among authors: bourgeois f. Transplant Cell Ther. 2024 Jun;30(6):626.e1-626.e11. doi: 10.1016/j.jtct.2024.03.016. Epub 2024 Mar 16. Transplant Cell Ther. 2024. PMID: 38494077

2

Landscape of phase 1 clinical trials for minors with cancer in the United States.

Nader JH, Neel DV, Shulman DS, Ma C, Bourgeois F, DuBois SG. Nader JH, et al. Among authors: bourgeois f. Pediatr Blood Cancer. 2020 Nov;67(11):e28694. doi: 10.1002/pbc.28694. Epub 2020 Sep 4. Pediatr Blood Cancer. 2020. PMID: 32886429 Free PMC article.

3

High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021.

Pathak K, Narang C, Hwang TJ, Espinoza JC, Bourgeois FT. Pathak K, et al. JAMA Pediatr. 2023 Jan 1;177(1):98-100. doi: 10.1001/jamapediatrics.2022.4131. JAMA Pediatr. 2023. PMID: 36342722 Free PMC article.

4

Personal Protective Equipment for COVID-19: Distributed Fabrication and Additive Manufacturing.

Sinha MS, Bourgeois FT, Sorger PK. Sinha MS, et al. Am J Public Health. 2020 Aug;110(8):1162-1164. doi: 10.2105/AJPH.2020.305753. Epub 2020 Jun 18. Am J Public Health. 2020. PMID: 32552025 Free PMC article. No abstract available.

5

National Trends in Disease Activity for COVID-19 Among Children in the US.

Hutch MR, Liu M, Avillach P; Consortium for Clinical Characterization of COVID-19 by EHR (4CE); Luo Y, Bourgeois FT. Hutch MR, et al. Front Pediatr. 2021 Jul 8;9:700656. doi: 10.3389/fped.2021.700656. eCollection 2021. Front Pediatr. 2021. PMID: 34307261 Free PMC article.

6

Correlation Between National Institutes of Health Funding for Pediatric Research and Pediatric Disease Burden in the US.

Rees CA, Monuteaux MC, Herdell V, Fleegler EW, Bourgeois FT. Rees CA, et al. JAMA Pediatr. 2021 Dec 1;175(12):1236-1243. doi: 10.1001/jamapediatrics.2021.3360. JAMA Pediatr. 2021. PMID: 34515752 Free PMC article.

7

National Institutes of Health Funding Priorities-Reply.

Rees CA, Monuteaux MC, Bourgeois FT. Rees CA, et al. JAMA Pediatr. 2022 Mar 1;176(3):325. doi: 10.1001/jamapediatrics.2021.5368. JAMA Pediatr. 2022. PMID: 34962553 No abstract available.

8

Data Sharing for Pediatric Clinical Trials Funded by the US National Institutes of Health.

Narang C, Ouvina M, Rees CA, Bourgeois FT. Narang C, et al. JAMA Netw Open. 2023 Jul 3;6(7):e2325342. doi: 10.1001/jamanetworkopen.2023.25342. JAMA Netw Open. 2023. PMID: 37490293 Free PMC article.

9

Quantifying proportion of treatment effect by surrogate endpoint under heterogeneity.

Guo X, Bourgeois FT, Cai T. Guo X, et al. Among authors: bourgeois ft. Stat Methods Med Res. 2024 May 8:9622802241247719. doi: 10.1177/09622802241247719. Online ahead of print. Stat Methods Med Res. 2024. PMID: 38717356

10

Variation and Trends in Charges for Pediatric Care in Massachusetts Emergency Departments, 2000-2011.

Monuteaux MC, Bourgeois FT, Mannix R, Samnaliev M, Stack AM. Monuteaux MC, et al. Acad Emerg Med. 2015 Oct;22(10):1164-71. doi: 10.1111/acem.12761. Epub 2015 Sep 22. Acad Emerg Med. 2015. PMID: 26394061 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

365 results

Search Page